Assembly Biosciences Inc. ASMB
$23.12
▲ +1.91% 24H
About
Assembly Biosciences Inc. is a clinical-stage biotechnology company focused on developing novel antiviral therapeutics for serious viral diseases worldwide. Its pipeline features long-acting helicase-primase inhibitors ABI-5366 and ABI-1179, currently in Phase 1a/1b clinical studies targeting recurrent genital herpes c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees73
TickerASMB
Statistics
Market Cap$367.4M
Revenue (TTM)$72.3M
Net Income-$6.1M
Net Margin-8.5%
EPS$-0.55
P/E280.25
P/S6.25
P/B1.79
EV/EBITDA-10.20
ROE-5.7%
Dividend Yield—
Price$23.12
Data: Twelve Data · Revenue = mcap / P/S